NPPA Retail Price Fixation for Pharmaceutical Formulations
The National Pharmaceutical Pricing Authority (NPPA), under the Ministry of Chemicals and Fertilizers, has issued an order dated November 28, 2025 fixing the retail price (exclusive of Goods and Services Tax, GST) for several drug formulations.
NPPA Fixes Retail Prices for 28 Formulations, Including Diabetes and Hypertension Drugs
The National Pharmaceutical Pricing Authority (NPPA) has issued an order to fix the retail prices for 28 specific drug formulations under the powers conferred by the Drugs (Prices Control) Order, 2013 (DPCO, 2013). This order, dated November 4, 2025, sets the maximum retail price, exclusive of Goods and Services Tax (GST), for each formulation manufactured by the specified companies.
NPPA Fixes Retail Prices for Nine New Drugs
The National Pharmaceutical Pricing Authority (NPPA), in a decisive move to regulate the cost of essential medicines, has officially fixed the retail prices for nine new drug formulations. This order, issued on September 15, 2025, sets the maximum prices for a range of new medicines, including advanced combination therapies for pain management, diabetes, and cardiovascular conditions. The action is in line with the objectives of the Drugs (Prices Control) Order, 2013 (DPCO, 2013).
NPPA Fixes Retail Prices for Drug Formulations
The National Pharmaceutical Pricing Authority (NPPA) has fixed the retail prices for 42 new drug formulations and approved an increased ceiling price for Meropenem Powder for Injection manufactured with special features by M/s Gufic Biosciences Limited. This decision, effective August 29, 2025, acknowledges the unique properties of the company’s dual-chamber bag formulation.
Government Reinforces Drug Price Regulation & Announces Significant Savings for Patients
The Government of India continues to enforce strict drug price regulations through the Drugs (Prices Control) Order, 2013 (DPCO, 2013), resulting in substantial savings for patients, particularly for life-saving medicines. This information was provided by the Union Minister of State for Chemicals and Fertilizers in a written reply in the Lok Sabha on August 8, 2025.
NPPA Fixes Retail Prices for 41 Essential Drug Formulations
The National Pharmaceutical Pricing Authority (NPPA) has issued an order on June 3, 2025, fixing the retail prices for 41 specific drug formulations. The newly fixed retail prices are exclusive of Goods and Services Tax (GST) and are applicable to the formulations as specified by their strength, unit, and the respective manufacturer and marketing company. Manufacturers are permitted to add GST only if it has been actually paid or is payable to the Government.
NPPA Sets Retail Prices for 80 New Drugs
The National Pharmaceutical Pricing Authority (NPPA), under the Ministry of Chemicals and Fertilizers, has announced the fixation of retail prices for 80 new drug formulations, aiming to ensure affordability and accessibility for consumers.
Correction In Price Issued For Synchrobreathe Inhaler
The price of the Synchrobreathe Inhaler for Budesonide Inhalation (MDI) 200 mcg/dose for 200 doses has therefore been revised to correct a typographical error. It is now fixed at Rs. 81.20 pe.r inhaler
NPPA Fixes Retail Price for Cilnidipine & Telmisartan Tablets
Each film coated Cilnidipine & Telmisartan Tablet shall bear the retail price of Rs. 14.15. This price applies to tablets manufactured by M/s Akums Drugs & Pharmaceuticals Ltd. and marketed by M/s Glenmark Pharmaceuticals Limited.
NPPA Revises Ceiling Prices of Azithromycin & Amoxicillin + Clavulanic Acid
Manufacturers selling these formulations (branded or generic) above the revised ceiling price (plus applicable GST) must immediately revise their prices downwards to comply. Retailers and dealers must prominently display the price list provided by the manufacturer.
NPPA Fixes Retail Prices For 42 Formulations
The National Pharmaceutical Pricing Authority (NPPA) has fixed the retail prices for 42 pharmaceutical formulations. These prices are exclusive of Goods and Services Tax, if applicable. These prices were notified on February 7, 2025.
Drug Price Display Mandatory for Online and On-Site Pharmacies
Online pharmacies operating through websites, portals, mobile apps, e-commerce platforms, or any other online mode are equally obligated to display the current price list of drugs as brick-and-mortar stores.